| 摘要 |
Disclosed are a method for identifying a compound for inhibiting retrovirus infectivity by selectively inhibiting or disrupting the interaction between a retroviral Gag protein and a Ubc9 protein, a therapeutic compound that selectively inhibits or disrupts the interaction between a retroviral Gag protein and a Ubc9 protein, a method to inhibit retroviral infectivity in a patient, a retroviral vaccine, and methods of use thereof.
|
